Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Stem Cells. 2014 Mar;32(3):684–693. doi: 10.1002/stem.1539

Figure 3. Blocking mAb against α6-integrin decreasedvasculogenic potential of HemSC.

Figure 3

A- HemSC suspended in Matrigel with α6-integrin blocking mAb or control mAb and injected s.c. into nude mice. Representative photographs of Matrigel explants at day10 after injection with corresponding histological sections stained with H&E. Black arrowheads point to luminal structures with red blood cells. Scale bar = 50 μm.

B- Quantification of lumens with red blood cells, reported as vessels/mm2. Data are mean ± SEM.

C- Immunohistochemical staining for human CD31 in implants after 10 days (scale bars, 50 μm).